Work

Treatment Outcome and Safety of Durvalumab After Concurrent Chemoradiotherapy in Elderly Patients With Unresectable Stage III Non-Small Cell Lung Cancer

Year: 2024

Type: conference-abstract

DOI: 10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a4948

Authors: S.J. Kim, N.Y. Kim, S. Chung, J.-H. Choi, I.G. Hyun, Y. Yeo, J.Y. Park, S.H. Jang, T. Kim, Y.S. Sim, C.Y. Lee, J. Kim

Institutions: Hallym University Dongtan Sacred Heart Hospital, Hallym University Sacred Heart Hospital, Hallym University Kangnam Sacred Heart Hospital, Hallym University, Hallym University Chuncheon Sacred Heart Hospital

Language: English

Topic: Lung Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4396502396

Cites:

Cited by:

Related to: 10